New Key Statistics Module, Z-Score and F-Score
WAR:CBD Key Ratios
| Market Cap zł M | 21.33 |
| Enterprise Value zł M | 17.19 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.51 |
| Price/Sales | 433.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) zł M | -- |
| EPS (TTM) zł | -0.04 |
| Beneish M-Score | -1.49 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 20.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -10.41 |
| EV-to-EBITDA | -10.71 |
| PEG | -- |
| Shares Outstanding M | 49.20 |
| Net Margin (%) | -2,928.00 |
| Operating Margin % | -3,258.00 |
| Pre-tax Margin (%) | -3,328.00 |
| Quick Ratio | 10.39 |
| Current Ratio | 10.63 |
| ROA % (ttm) | -47.27 |
| ROE % (ttm) | -54.82 |
| ROIC % (ttm) | -319.34 |
| Dividend Yield % | -- |
| Altman Z-Score | 26.32 |
WAR:CBD Number of Guru Trades
WAR:CBD Volume of Guru Trades
Gurus Latest Trades with WAR:CBD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WAR:CBD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers